Safety and efficacy of pegfilgrastim administration on the same day as myelosuppressive chemotherapy (CT) in women with ovarian or primary peritoneal cancer

被引：0
|
作者：
Schuman, S. I. [1 ]
Lambrou, N. [1 ]
Robson, K. [1 ]
Gluck, S. [1 ]
Myriounis, N. [1 ]
Pearson, J. [1 ]
Alvarez, E. [1 ]
Crisp, M. P. [1 ]
Twiggs, L. B. [1 ]
Lucci, J. A. [1 ]
机构：
[1] Univ Miami, Jackson Mem Hosp, Miami, FL 33136 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
16009
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy, safety, and cost-effectiveness (CE) analysis of pegfilgrastim (P) and lenograstim (L) in patients (pts) with nonmetastatic breast cancer (nmBC) receiving myelosuppressive chemotherapy (mCT)
    Papa, Anselmo
    Rossi, Luigi
    Tomao, Federica
    Ricci, Fabio
    Giordani, Erika
    Spinelli, Gian Paolo
    Lo Russo, Giuseppe
    Basso, Enrico
    Verrico, Monica
    Zaccarelli, Eleonora
    Rinaldi, Giulia
    Stati, Valeria
    Pasciuti, Giulia
    Strudel, Martina
    Zoratto, Federica
    Tomao, Silverio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] Safety of same-day administration of gemcitabine plus cisplatin chemotherapy for urothelial carcinoma
    Tsuru, Ibuki
    Niimi, Fusako
    Honda, Sachi
    Azuma, Takeshi
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2021, 14 (03)
  • [43] A single-center, observational study comparing neutropenic event rates for patients receiving pegfilgrastim on the same day or the day after chemotherapy administration
    Baribeault, DM
    Blanchard, R
    [J]. PHARMACOTHERAPY, 2004, 24 (10): : 1450 - 1450
  • [44] Effect of timing of pegfilgrastim administration on absolute neutrophil count (ANC) trajectory among cancer patients (pts) receiving myelosuppressive chemotherapy (chemo).
    Li, Yanli
    Klippel, Zandra Karina
    Shih, Xiaolong
    Wang, Hong
    Reiner, Maureen
    Page, John
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [45] Niraparib in the maintenance treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: safety and efficacy
    Liu, Marisa C.
    Sutedja, Joyce
    Tewari, Krishnansu S.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (05) : 475 - 480
  • [46] Chemotherapy induced neutropenia in rats following administration of eflapegrastim or pegfilgrastim on the same day at three different timepoints and at 24 hours post-chemotherapy
    Kim, Yu-Yon
    Kim, Eunjung
    Han, Hyesun
    Baek, Seungjae
    Chawla, Shanta
    Kolli, Prasad
    Bhat, Gajanan
    Lebel, Francois
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [47] The role of specialty training in the administration of chemotherapy for women with ovarian cancer
    Breed, C.
    Brennecke, A.
    Flink, D.
    Guntupalli, S.
    [J]. GYNECOLOGIC ONCOLOGY, 2017, 147 (01) : 213 - 214
  • [48] Safety and Potential Benefit of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal Carcinomatosis From Primary or Recurrent Ovarian Cancer
    Roviello, Franco
    Pinto, Enrico
    Corso, Giovanni
    Pedrazzani, Corrado
    Caruso, Stefano
    Filippeschi, Marco
    Petrioli, Roberto
    Marsili, Stefania
    Mazzei, Maria Antonietta
    Marrelli, Daniele
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2010, 102 (06) : 663 - 670
  • [49] Evaluation of the Hematologic Safety of Same Day Versus Standard Administration (24-to 72-Hour Delay) of Pegfilgrastim in Gynecology Oncology Patients Undergoing Cytotoxic Chemotherapy
    Billingsley, Caroline C.
    Jacobson, Samuel N.
    Crafton, Sarah M.
    Crim, Aleia K.
    Li, Quan
    Hade, Erinn M.
    Cohn, David E.
    Fowler, Jeffrey M.
    Copeland, Larry J.
    Salani, Ritu
    Backes, Floor J.
    O'Malley, David M.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (07) : 1331 - 1336
  • [50] Efficacy and safety of pegfilgrastim in prophylaxis of chemotherapy-induced neutropenia in breast cancer patients.
    Xia, Wen
    Xu, Fei
    Yuan, Zhongyu
    Xu, Ruilian
    Jiang, Yi
    Wu, Zhiyong
    Lu, Qianyi
    Zheng, Qiufan
    Hong, Ruoxi
    Jiang, Kuikui
    Huang, Jiajia
    An, Xin
    Bi, XiWen
    Hong, Yun
    Pang, Danmei
    Zhang, Anqin
    Wang, Xianming
    Zhang, Qing
    Zhang, Haibo
    Wang, Shusen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345